Role of diabetes mellitus in the clinical course and outcome of SARS-CoV-2 infected patients

被引：0
作者：
Helena C. Maltezou
Androula Pavli
Paraskevi Tsonou
Asimina Balaska
Vasilios Raftopoulos
Kalliopi Papadima
Anastasia Andreopoulou
Anastasios Tentolouris
Maria N. Gamaletsou
Nikolaos V. Sipsas
Nikolaos Tentolouris
机构：
[1] National Public Health Organization,Directorate of Research, Studies and Documentation
[2] National Public Health Organization,Department of Travel Medicine
[3] National Public Health Organization,Directorate of Non
[4] HIV Surveillance Division,Communicable Diseases
[5] National Public Health Organization,Department of Respiratory Infections, Directorate of Epidemiological Surveillance and Interventions for Infectious Diseases
[6] National Public Health Organization,First Department of Propaedeutic Internal Medicine, Medical School
[7] National and Kapodistrian University of Athens,Pathophysiology Department, Medical School
[8] National and Kapodistrian University of Athens,undefined
来源：
Hormones | 2022年 / 21卷
关键词：
COVID-19; SARS-CoV-2; Diabetes mellitus; Comorbidities; Clinical course; Outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：221 / 227
页数：6
相关论文
共 194 条
[11]  
Yu T(2020)Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020 Euro Surveill 25 2000323-84
[12]  
Wang Y(2006)Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS Diabet Med 23 623-833
[13]  
Pan S(2016)Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia Virol Sin 31 81-908
[14]  
Zou S(2020)Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study Lancet Diabetes Endocrinol 8 823-1184
[15]  
Yuan S(2020)Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes J Diabetes 12 895-undefined
[16]  
Shang Y(2021)Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications J Biomed Sci 28 9-undefined
[17]  
Chen R(2020)Natural history of COVID-19 and therapeutic options Exp Rev Clin Immunol 16 1159-undefined
[18]  
Liang W(2021)Post-COVID syndrome: an insight on its pathogenesis Vaccines (Basel) 9 497-undefined
[19]  
Jiang M(undefined)undefined undefined undefined undefined-undefined
[20]  
Guan W(undefined)undefined undefined undefined undefined-undefined
12345678910